Friday, 19th September The Pancreas Summit 2025

• Artificial Intelligence in Pancreatobiliary Endoscopy: A Brave New World - Miguel José Mascarenhas Saraiva
• Clonal Heterogeneity in Human Pancreatic Ductal Adenocarcinoma and It’s Impact on Tumor Progression - Diane Simeone

• Framing Pancreatitis as a Disease of Disadvantage: A Population-Based Study from Tasmania - Richard Turner
• Research Advances of Traditional Chinese Medicine in Acute Pancreatitis - Wei Huang
• RAGE Inhibitor Azeliragon Reduces Pyroptosis in Severe Acute Pancreatitis by Blocking the Extracellular Histones/LPS-RAGE Axis - Qiqi Wang
• FIT2/LC-CoA-Mediated Intrapancreatic Fat Deposition and Acinar Cell Calcium Overload in Acute Pancreatitis - Yuying Li
• Investigating miR-146a as a Key Modulator of Inflammatory Responses in Pancreatitis - Mohamed Saad
• Targeting PSC Activation and PSC–Macrophage Interaction in Alcoholic Chronic Pancreatitis via IL-4 Blockade and Simvastatin - Parvathy Rajan

• Diagnosis - & Work up - Brett Knowles
• P-NET and Genetic Disorders (MEN 1–4, VHL, SDHD, NF1, TS) - Christopher Yates
• Role of Surgery - Benjamin Loveday
• Medical Management of P-NET - Michael Michael
• Peptide Receptor Radionuclide Therapy (PRRT) - Javad Saghebi
• EUS-Guided Ablation - Stephen Pereira

• Association Between Trajectories of Serum Chloride and Prolonged Organ Failure Among Patients With Predicted Severe Acute Pancreatitis: Secondary Analysis of Two Multicenter Trials - Lu Ke
• Randomized Controlled Trial of Immediate Full Calorie Regular Diet (RD) Versus Clear Liquid Diet (CLD) for Mild to Moderate Acute Pancreatitis - James Buxbaum

• Targeting Oncogenic and Metabolic Dependencies in PDAC to Remodel the Tumor Microenvironment - Saranya Pounraj
• Octreotate avid intrapancreatic lesions – intrapancreatic splenunculi (IPS) masquerading as pancreatic neuroendocrine tumours (pNETs). - Bridget Addis
• Cancer cell-intrinsic ASC links innate immunity with mitochondrial metabolism in driving inflammasome-associated pancreatic tumorigenesis - Yu CJ Chey
• Comprehensive analysis of pancreatic cancer and stellate cell derived exosome lipid cargo: Potential mediators of pancreatic cancer-related diabetes. - Rohit Sarkar
• Blood Vessel Networks Generated from Human Induced Pluripotent Stem Cells for the Study of Metastasis - Connor Sherwood
• Initial perceptions of Australian clinicians participating in the SCANPatient clinical trial of synoptic reporting of CT scans to assess pancreatic cancer - Lin Li
• Identifying patients with pancreatic cancer in primary care: comparing the sensitivity of decision support tools. - Mary Waterhouse
• Prognostic Significance of ABO Blood Type in Patients with Advanced Pancreatic Cancer Treated with Nab-Paclitaxel Plus Gemcitabine - Kiyotsugu Iede
• Factors associated with pancreatectomy among individuals with pancreatic ductal adenocarcinoma in a retrospective cohort study - Arrisonia C Doubatty
• The international use of radiology synoptic report in pancreatic caner: a literature review - Chen Wang
• Distal Pancreatectomy with Celiac Axis Resection and Arterial Reconstruction: A 16-Year Experience with Focus on Arterial Patency and Ischemic Complications - Minako Nagai
• Multidisciplinary Meeting Presentation in Pancreatic Cancer: Insights from a Population-Based Registry - Sanuki Tissera
• Predicting The Storm: Predicting The Severity Of Acute Pancreatitis With MEWS (Modified Early Warning Score) - Sujit James
• The case of recurrent pancreatic fistula caused by pancreatic duct obstruction due to a metal clip used during the operation. - Hana Yoshimitsu
• Exocrine pancreatic insufficiency - kamran KN nazir
• Association between triglyceride-lipase index and incidence and duration of organ failure in patients with hypertriglyceridemia-associated acute pancreatitis   - Lu Ke
• Dihydroquercetin derived from Huanglong decoction ameliorates sever acute pancreatitis by modulating STAT3/ERK signaling pathway - Yan Shen
• AIR IN WALLED OFF PANCREATIC NECROSIS: INFECTED COLLECTION OR BOWEL FISTULA: A CASE SERIES - Aditya Kulkarni
• MANAGEMENT OF PSEUDOANEURYSM WITH EUS GUIDED COIL AND GLUE: CASE SERIES - Aditya Kulkarni
• ONE-THIRD OF PATIENTS WITH IDIOPATHIC RECURRENT ACUTE PANCREATITIS DEVELOP CHRONIC PANCREATITIS ON LONG-TERM FOLLOW-UP - Gauri Kumbhar

• Tailoring the Choice of First Line Therapy for Patients With Advanced Pancreatic Cancer - Prasad Cooray
• Improving Chemotherapy Penetration in Pancreatic Cancer - Ascend and Beyond - Andrew Dean
• Novel Approaches to Immunotherapy in Pancreatic Cancer - Neoimpact - Lorraine Chantrill
• Tailoring Adjuvant Therapy in PDAC – Dynamic Pancreas - Belinda Lee
• Neoadjuvant Therapy in PDAC – NeoFol R Trial - Jin-Young Jang

• Pancreatic Cancer-Related Diabetes - From a Clinician’s Perspective - Shounak Majumder
• Pancreatic Cancer-Related Diabetes - Novel Role of Pancreatic Stellate Cells - Chamini Perera
• Towards Earlier Diagnosis and Equitable Management of Pancreatic Cancer - Rachel Neale
• Predicting Pancreatic Cancer Risk in People With New-Onset Diabetes Mellitus - Mary Waterhouse
• Type 2 Diabetes Changes the Composition of Quiescent Pancreatic Stellate Cells into a Tumor-Prone Nature from the Precancerous Stage - Yutaro Hara

• Role of EUS vs Cross-Sectional Imaging i.e. Operability Criteria etc. - Benedict Devereaux
• Molecular Testing – A Must or Optional? - Albrecht Neesse
• Updates in Surgery for Locally Advanced / Borderline Resectable PDAC - Siobhan McKay
• 32P Microparticles Combined with Chemo - Nam Nguyen
• EUS Biliary Drainage – Is ERCP Still Required? - Kazumasa Nagai
• Management of GOO / Biliary Obstruction in Locally Advanced PDAC - Saurabh Gupta

Details

Drinks and canapes included

Cost

Complimentary for Full Registered Delegates
$70 for Additional Tickets

Whilst the cost of this ticket is included in your registration, it is important that you RSVP by selecting Welcome Reception in your registration for catering purposes.